Alcon AG (ALC)

NYSE
Currency in USD
84.88
-1.32(-1.53%)
Closed·
Pre Market
84.62-0.26(-0.31%)
·
ALC Scorecard
Full Analysis
Has raised its dividend for 5 consecutive years
ALC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
84.7586.18
52 wk Range
80.48101.10
Key Statistics
Edit
Prev. Close
84.88
Open
85.99
Day's Range
84.75-86.18
52 wk Range
80.48-101.1
Volume
1.36M
Average Volume (3m)
1.72M
1-Year Change
-4.04%
Book Value / Share
44.48
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ALC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
11 analysts have revised their earnings downwards for the upcoming period

Alcon AG News & Analysis

Show more

Alcon AG Company Profile

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon AG SWOT Analysis


Eye Care Evolution
Alcon navigates a competitive landscape while leveraging its robust product pipeline, balancing challenges and opportunities in the global eye care market.
Financial Resilience
Despite mixed Q2 2024 results, Alcon demonstrates strong operational efficiency with margins exceeding expectations. EPS projections indicate steady growth.
Competitive Dynamics
Explore how Alcon faces pressure from established players and innovative newcomers, potentially impacting its dominant position in the U.S. PC-IOL market.
Growth on the Horizon
Discover Alcon's multi-year upgrade cycle, including new surgical systems, glaucoma treatments, and expansion in China, with price targets ranging from $95 to $110.
Read full SWOT analysis

Alcon AG Earnings Call Summary for Q3/2024

  • Q3 sales up 6% YoY to $2.4B; core EPS rose 25% to $0.81; core operating margin at 20.6%
  • Record $1.3B free cash flow in first 9 months; FY revenue guidance updated to $9.8B-$9.9B
  • Upcoming launches: Precision7 contact lenses, Systane Pro tears; partnership with OcuMension in China
  • U.S. surgical market softness led to $150M revenue guidance reduction; contact lens growth trending down
  • Strong international sales growth in implantable lenses; positive feedback on Unity VCS surgical platform
Last Updated: 14-11-2024, 02:50 pm
Read Full Transcript

Compare ALC to Peers and Sector

Metrics to compare
ALC
Peers
Sector
Relationship
P/E Ratio
37.7x5.6x−0.4x
PEG Ratio
5.680.250.00
Price/Book
1.9x2.4x2.6x
Price / LTM Sales
4.3x2.8x3.0x
Upside (Analyst Target)
24.8%22.1%52.3%
Fair Value Upside
Unlock10.0%9.4%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 2.26%
Dividend Yield
0.25%
Industry Median 0.75%
Annualised payout
0.22
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 14, 2025
EPS / Forecast
0.73 / 0.76
Revenue / Forecast
2.45B / 2.51B
EPS Revisions
Last 90 days

ALC Income Statement

FAQ

What Is the Alcon AG (ALC) Stock Price Today?

The Alcon AG stock price today is 84.88.

What Stock Exchange Does Alcon AG Trade On?

Alcon AG is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Alcon AG?

The stock symbol for Alcon AG is "ALC."

Does Alcon AG Pay Dividends? What’s The Current Dividend Yield?

The Alcon AG dividend yield is 0.26%.

What Is the Alcon AG Market Cap?

As of today, Alcon AG market cap is 42.51B.

What Is Alcon AG's Earnings Per Share (TTM)?

The Alcon AG EPS (TTM) is 2.26.

When Is the Next Alcon AG Earnings Date?

Alcon AG will release its next earnings report on 19 Aug 2025.

From a Technical Analysis Perspective, Is ALC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Alcon AG Stock Split?

Alcon AG has split 0 times.

How Many Employees Does Alcon AG Have?

Alcon AG has 25000 employees.

What is the current trading status of Alcon AG (ALC)?

As of 18 Jun 2025, Alcon AG (ALC) is trading at a price of 84.88, with a previous close of 84.88. The stock has fluctuated within a day range of 84.75 to 86.18, while its 52-week range spans from 80.48 to 101.10.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.